Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:03 pm Sale |
2021-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
EcoR1 Capital, LLC | 43,031 2.000% |
-113,104 (-72.44%) |
Filing History |
| 2022-02-14 3:02 pm Purchase |
2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital, LLC | 3,468,944 8.800% |
376,726 (+12.18%) |
Filing History |
| 2022-02-14 3:01 pm Purchase |
2021-12-31 | 13G | Morphic Holding, Inc. MORF |
EcoR1 Capital, LLC | 3,951,566 10.700% |
1,111,682 (+39.15%) |
Filing History |
| 2022-02-14 2:38 pm Unchanged |
2021-12-31 | 13G | Atreca, Inc. BCEL |
EcoR1 Capital, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 2:17 pm Sale |
2021-12-31 | 13G | Geron Corporation GERN |
EcoR1 Capital, LLC | 9,615,385 2.900% |
-18,939,925 (-66.33%) |
Filing History |
| 2022-02-14 2:16 pm Sale |
2021-12-31 | 13G | Atreca, Inc. BCEL |
EcoR1 Capital, LLC | 0 0.000% |
-2,426,685 (Position Closed) |
Filing History |
| 2022-02-14 2:15 pm Unchanged |
2020-12-31 | 13G | Savara Inc. SVRA |
EcoR1 Capital, LLC | 3,040,540 5.300% |
0 (Unchanged) |
Filing History |
| 2022-02-14 2:15 pm Sale |
2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
EcoR1 Capital, LLC | 253,897 1.700% |
-111,111 (-30.44%) |
Filing History |
| 2022-02-14 1:39 pm Purchase |
2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
EcoR1 Capital, LLC | 6,319,232 9.300% |
1,384,300 (+28.05%) |
Filing History |
| 2022-02-14 1:38 pm Sale |
2021-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY |
EcoR1 Capital, LLC | 1,060,010 3.000% |
-1,473,625 (-58.16%) |
Filing History |
| 2022-02-14 1:38 pm Sale |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
EcoR1 Capital, LLC | 0 0.000% |
-4,368,500 (Position Closed) |
Filing History |
| 2022-02-14 1:37 pm Sale |
2021-12-31 | 13G | AC Immune SA ACIU |
EcoR1 Capital, LLC | 749,585 0.900% |
-3,952,575 (-84.06%) |
Filing History |
| 2022-02-14 12:49 pm Purchase |
2021-12-31 | 13G | Xencor, Inc. XNCR |
EcoR1 Capital, LLC | 4,906,106 8.400% |
359,034 (+7.90%) |
Filing History |
| 2022-02-02 7:52 pm Purchase |
2022-01-27 | 13G | Galapagos NV GLPG |
EcoR1 Capital, LLC | 3,407,246 5.200% |
3,407,246 (New Position) |
Filing History |
| 2022-01-31 4:39 pm Purchase |
2022-01-21 | 13G | Kura Oncology, Inc. KURA |
EcoR1 Capital, LLC | 4,543,447 6.800% |
2,770,410 (+156.25%) |
Filing History |
| 2022-01-13 6:45 pm Purchase |
2022-01-12 | 13D | Prothena Corporation plc PRTA |
EcoR1 Capital, LLC | 11,584,280 24.900% |
2,157,640 (+22.89%) |
Filing History |
| 2021-12-10 5:24 pm Sale |
2021-12-10 | 13G | Odonate Therapeutics, Inc. ODTC |
EcoR1 Capital, LLC | 0 0.000% |
-0 (Position Closed) |
Filing History |
| 2021-12-10 5:08 pm Purchase |
2021-12-01 | 13G | Atea Pharmaceuticals, Inc. AVIR |
EcoR1 Capital, LLC | 5,376,134 6.500% |
5,376,134 (New Position) |
Filing History |
| 2021-11-18 1:03 pm Purchase |
2021-11-17 | 13G | Odonate Therapeutics, Inc. ODTC |
EcoR1 Capital, LLC | 0 14.800% |
0 (+69.51%) |
Filing History |
| 2021-11-16 12:20 pm Purchase |
2021-11-05 | 13G | 2seventy bio, Inc. TSVT |
EcoR1 Capital, LLC | 1,890,663 8.100% |
1,890,663 (New Position) |
Filing History |